TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23663518

Group type: EXPERIMENTAL
Intervention: LED application (irradiated for 30 s, energy received at each point 41.7 J)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 30
Study: 21859184

Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference interpretation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dynamic psychotherapy without transference interpretation
Number of subjects: 100
Study: 20481050

Group type: EXPERIMENTAL
Intervention: Structural resonance electromagnetic therapy (SREMT) - 10-12 daily sessions of 43 minutes each on a Rematerp apparatus.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group receiving the same medical and physiotherapeutic treatment without SREMT.
Number of subjects: 120
Study: 17565788

Group type: EXPERIMENTAL
Intervention: Activation of persistence
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prime (absence of persistence)
Number of subjects: 0
Study: 15105203

Group type: EXPERIMENTAL
Intervention: i.v. midazolam (0.09 mg/kg)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (local anesthetic only)
Number of subjects: 125
Study: 11193231

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Desipramine 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg
Number of subjects: 12
Study: 9625132

Group type: EXPERIMENTAL
Intervention: Fish oil extract (EPA 3.2 g, DHA 2.4 g)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sunflower oil (placebo)
Number of subjects: 18
Study: 7935997

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study: 3065156

Group type: EXPERIMENTAL
Intervention: Balloon dilatation
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bougie dilatation
Number of subjects: 65
Study: 30954341

Group type: EXPERIMENTAL
Intervention: High-nitrate salad (twice daily for 10 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Canned vegetable control (beans, corn, or peas)
Number of subjects: 10
Study: 28502543

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 3447

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 3447
Study: 26721132

Group type: EXPERIMENTAL
Intervention: Shallow needling (once a day, 5 times a week for 6 weeks)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Medication (3 mg eszopiclone tablets orally before sleep, once every night for 6 weeks)
Number of subjects: 96
Study: 23882870

Group type: EXPERIMENTAL
Intervention: Light cigarette (0.6 mg of nicotine, 8 mg of tar, and 9 mg of carbon monoxide)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Regular cigarette (0.9 mg of nicotine, 12 mg of tar, and 12 mg of carbon monoxide)
Number of subjects: 22
Study: 21729284

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg) administered orally at 21:00 h for five consecutive days
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study: 18997640

Group type: EXPERIMENTAL
Intervention: Slit-lamp biomicroscopy (SLB)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Photographic grading of fundus photographs (FP)
Number of subjects: 129
Study: 16990197

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 717

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 717
Study: 14961588

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA) screening
Number of subjects: 78392

Group type: COMPARATOR
Intervention: Control group (no VIA screening)
Number of subjects: 78392

Group type: EXPERIMENTAL
Intervention: VIA screening
Number of subjects: 78392
Study: 11685385

Group type: EXPERIMENTAL
Intervention: 10 min of moderate intensity exercise on a stationary cycle
Number of subjects: 78

Group type: COMPARATOR
Intervention: Waiting passively (control condition 1)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Watching a video (control condition 2)
Number of subjects: 78
Study: 9221864

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerine (0.2 percent glyceryl trinitrate ointment)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Topical anesthetic gel (lignocaine)
Number of subjects: 35
Study: 8213579

Group type: EXPERIMENTAL
Intervention: rt-PA (10 mg bolus, followed by 50 mg in the first hour, and 20 mg/hour for the next 2 hours)
Number of subjects: 253

Group type: COMPARATOR
Intervention: streptokinase (375,000 IU bolus, followed by 1,125,000 IU over 1 hour)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 253

Group type: COMPARATOR
Intervention: streptokinase
Number of subjects: 253
Study: 3583491

Group type: EXPERIMENTAL
Intervention: Fenticonazole 2% cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Miconazole 2% cream
Number of subjects: 40
Study: 30969246

Group type: EXPERIMENTAL
Intervention: Anodal tDCS on F4
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anodal tDCS on P4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS on F4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS on P4
Number of subjects: 60
Study: 27563740

Group type: EXPERIMENTAL
Intervention: Extremely high stress in male students
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Extremely high stress in female students
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Conflict with a teacher (male students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Trouble with parents (male students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Peer relationships (male students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Conflict with parents (female students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Peer relationships (female students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Appearance (female students)
Number of subjects: 442113

Group type: EXPERIMENTAL
Intervention: Financial difficulty (female students)
Number of subjects: 442113
Study: 26898862

Group type: EXPERIMENTAL
Intervention: Intralesional steroid injection combined with acid-suppressive therapy (experimental group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Acid-suppressive therapy only (control group)
Number of subjects: 88
Study: 24529580

Group type: EXPERIMENTAL
Intervention: Silodosin 8-mg once-daily (QD)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Silodosin 4-mg twice-daily (BID)
Number of subjects: 532
Study: 22262012

Group type: EXPERIMENTAL
Intervention: Structured warm-up program
Number of subjects: 14
Study: 19618305

Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rt‐PA, alteplase) for acute ischaemic stroke
Number of subjects: 1118
Study: 17499988

Group type: EXPERIMENTAL
Intervention: Endocrine therapy for breast cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laboratory and hormone replacement studies
Number of subjects: 0
Study: 15072701

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) doses of 450 microg and 400 microg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three mathematical correction methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: None of the correction methods
Number of subjects: 0
Study: 12358259

Group type: EXPERIMENTAL
Intervention: Peritoneovenous shunt
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large-volume paracentesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Model validation
Number of subjects: 0
Study: 10188768

Group type: EXPERIMENTAL
Intervention: SIRS plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutralizing SIRS plasma of granulocyte macrophage-colony-stimulating factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human IL-10 (10 ng/mL)
Number of subjects: 0
Study: 7493146

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (60 mg/kg, i.v.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline (5 ml)
Number of subjects: 24
Study: 2672869

Group type: EXPERIMENTAL
Intervention: 20-gauge needle
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 25-gauge needle
Number of subjects: 2
Study: 520877

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no compression)
Number of subjects: 39
Study: 30995433

Group type: EXPERIMENTAL
Intervention: Insulin glargine + Exenatide (Iglar + GLP-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin glargine (Iglar)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exenatide (GLP-1)
Number of subjects: 0
Study: 28026920

Group type: EXPERIMENTAL
Intervention: Naltrexone sustained release (SR) 32 mg / Bupropion SR 360 mg + Comprehensive Lifestyle Intervention (CLI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (standard diet/exercise advice)
Number of subjects: 0
Study: 25827441

Group type: EXPERIMENTAL
Intervention: Empagliflozin 12.5 mg twice daily
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Empagliflozin 5 mg twice daily
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1094
Study: 24438460

Group type: EXPERIMENTAL
Intervention: Usual care plus SFP 10‐14 UK
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 22387567

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 272

Group type: COMPARATOR
Intervention: Cinacalcet plus low-dose vitamin D
Number of subjects: 272
Study: 19145426

Group type: EXPERIMENTAL
Intervention: Holmium laser ablation of the prostate (HoLAP) using VersaPulse 100‐W laser (2.0 J/50 Hz or 3.2 J/25 Hz)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Holmium laser ablation of the prostate (HoLAP)
Number of subjects: 86
Study: 17555693

Group type: EXPERIMENTAL
Intervention: Debridement (Group I, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No debridement (Group II, n=20)
Number of subjects: 40
Study: 15459619

Group type: EXPERIMENTAL
Intervention: Patient education intervention (single-page form distributed at triage desk for 8 weeks)
Number of subjects: 860

Group type: COMPARATOR
Intervention: Control group (no patient education intervention)
Number of subjects: 860
Study: 11474913

Group type: EXPERIMENTAL
Intervention: Health education program with toothpaste and toothbrushes
Number of subjects: 727

Group type: EXPERIMENTAL
Intervention: Health education program only
Number of subjects: 727

Group type: EXPERIMENTAL
Intervention: Toothpaste and toothbrushes only
Number of subjects: 727

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 727
Study: 9571947

Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 19

Group type: COMPARATOR
Intervention: General Anaesthesia
Number of subjects: 19
Study: 8052457

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study: 1696670

Group type: EXPERIMENTAL
Intervention: Nicardipine (4 doses: 1.25, 2.5, 5.0, and 10.0 mg administered by i.v. infusion over 40 min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nicardipine during exercise
Number of subjects: 22
Study: 1245165

Group type: EXPERIMENTAL
Intervention: 0.75 mg digoxin with 1100 mg magnesium-aluminium-silicate-hydrate (n=4)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.375 mg digoxin with 1100 mg magnesium-aluminium-silicate-hydrate (n=4)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.75 mg digoxin with 1000 mg dimagnesium-aluminium-trisilicate (n=5)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.375 mg digoxin with 1000 mg dimagnesium-aluminium-trisilicate (n=5)
Number of subjects: 9
Study: 30730816

Group type: EXPERIMENTAL
Intervention: Ultrafast shear wave elastography (SWE)
Number of subjects: 15
Study: 27640367

Group type: EXPERIMENTAL
Intervention: Word catheter
Number of subjects: 161

Group type: COMPARATOR
Intervention: Marsupialisation
Number of subjects: 161
Study: 26077126

Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP) + beetroot juice (BJ)
Number of subjects: 13
Study: 24090749

Group type: EXPERIMENTAL
Intervention: Statin use (current use within 2 months)
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Statin use (any use within 24 months)
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 4476

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 4476
Study: 22193345

Group type: EXPERIMENTAL
Intervention: Combined spinal epidural (CSE) analgesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural (E) analgesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IV pethidine analgesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CSE using bupivacaine or lidocaine
Number of subjects: 60
Study: 18807218

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 23
Study: 18700004

Group type: EXPERIMENTAL
Intervention: Lithium treatment during an 8-week open-label, randomized, escalating dose Pharmacokinetic Phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium treatment during a 16-week Long-Term Effectiveness Phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium treatment during a 28-week double-blind Discontinuation Phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium treatment during an 8-week open-label Restabilization Phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lithium treatment during an 8-week double-blind, parallel-group, placebo-controlled Efficacy Phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium treatment during an open-label Long-Term Effectiveness lasting either 16 or 24 weeks
Number of subjects: 0
Study: 15548718

Group type: EXPERIMENTAL
Intervention: Intradermal administration of granulocyte macrophage-colony stimulating factor around the excision site of stage I primary melanoma tumors
Number of subjects: 0
Study: 11796808

Group type: EXPERIMENTAL
Intervention: Prototype latex female condom
Number of subjects: 135

Group type: COMPARATOR
Intervention: Reality female condom
Number of subjects: 135
Study: 9495426

Group type: EXPERIMENTAL
Intervention: Tropisetron 0.5 mg
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Tropisetron 2 mg
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 7946944

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg twice daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4-hydroxypropranolol (4OHP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 3186373

Group type: EXPERIMENTAL
Intervention: Cleft palate group (35 subjects)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (68 subjects without cleft palates)
Number of subjects: 35
Study: 30883291

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30067581

Group type: EXPERIMENTAL
Intervention: Web-based parent-adolescent sexual communication program
Number of subjects: 492

Group type: COMPARATOR
Intervention: Web-based physical activity program
Number of subjects: 492
Study: 26242993

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 891

Group type: COMPARATOR
Intervention: Non-intervention control
Number of subjects: 891
Study: 25062651

Group type: EXPERIMENTAL
Intervention: Weight-based insulin glargine dose titration regimen
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Glucose level-based insulin glargine dose titration regimen
Number of subjects: 149

Group type: COMPARATOR
Intervention: Current dose-based insulin glargine dose titration regimen
Number of subjects: 149
Study: 21980058

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 μg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone propionate (50/250 μg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (250 μg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 19130643

Group type: EXPERIMENTAL
Intervention: Creatine (4 x 5 gxd-1) during days 15-21
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (maltodextrin; 4 x 5 gxd-1) during days 1-7
Number of subjects: 7
Study: 17877164

Group type: EXPERIMENTAL
Intervention: A + C vaccine
Number of subjects: 34543

Group type: COMPARATOR
Intervention: Vi polysaccharide vaccine
Number of subjects: 34543
Study: 15165407

Group type: EXPERIMENTAL
Intervention: Yogic practices (selected asanas for 45 minutes, pranayama for 15 minutes in the morning; preparatory postures for 15 minutes, pranayama for 15 minutes, meditation for 30 minutes in the evening) for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Body flexibility exercises for 40 minutes, slow running for 20 minutes in the morning; games for 60 minutes in the evening for 3 months
Number of subjects: 30
Study: 14664747

Group type: EXPERIMENTAL
Intervention: Vitexina
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9689804

Group type: EXPERIMENTAL
Intervention: Amosite exposure
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Chrysotile exposure
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Crocidolite exposure
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Mixed fibre exposures
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Tremolite exposure
Number of subjects: 83
Study: 8082522

Group type: EXPERIMENTAL
Intervention: Extra therapeutic shoe coverage
Number of subjects: 3428

Group type: COMPARATOR
Intervention: Control group (standard Medicare coverage)
Number of subjects: 3428
Study: 2645508

Group type: EXPERIMENTAL
Intervention: Tetrazepam
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Tizanidine
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: All treatments (Tetrazepam, Baclofen, Tizanidine)
Number of subjects: 47
Study: 30352770

Group type: EXPERIMENTAL
Intervention: Biomechanical therapy with a foot-worn biomechanical device
Number of subjects: 50
Study: 29071986

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy combined with nutrition consultation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nutrition consultation (control group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 71
Study: 25892145

Group type: EXPERIMENTAL
Intervention: Afatinib (40 mg/day)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Methotrexate (40 mg/m2 per week)
Number of subjects: 483
Study: 24165884

Group type: EXPERIMENTAL
Intervention: Etravirine 200 mg bid for 14 days with cocktail on days 1 and 14
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etravirine 200 mg bid for 12 days with digoxin on day 8
Number of subjects: 0
Study: 22852050

Group type: EXPERIMENTAL
Intervention: Carbohydrate-only (CHO; 75 g per beverage)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-carbohydrate/low-protein (HCLP; 45 g CHO, 25 g Pro, 0.5 g fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-protein (LCHP; 8 g CHO, 55 g Pro, 4 g fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EX2 performance with CHO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EX2 performance with HCLP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EX2 performance with LCHP
Number of subjects: 12

Group type: COMPARATOR
Intervention: All treatments (CHO, HCLP, LCHP)
Number of subjects: 12
Study: 19339121

Group type: EXPERIMENTAL
Intervention: ReSUS scale
Number of subjects: 230
Study: 17519069

Group type: EXPERIMENTAL
Intervention: LOP/SIM 2 mg/125 mg
Number of subjects: 483

Group type: COMPARATOR
Intervention: LOP 2 mg
Number of subjects: 483

Group type: COMPARATOR
Intervention: SIM 125 mg
Number of subjects: 483

Group type: COMPARATOR
Intervention: PBO
Number of subjects: 483
Study: 14688160

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg 3 h prior to SE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral misoprostol (400 microg 3 h prior to SE)
Number of subjects: 100
Study: 11768727

Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 32
Study: 9260007

Group type: COMPARATOR
Intervention: Tramadol (10 mg PCA bolus)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Tramadol + Droperidol (10 mg tramadol + 0.1 mg droperidol PCA bolus)
Number of subjects: 34
Study: 8500303

Group type: EXPERIMENTAL
Intervention: Visual Field Quality Control Procedures
Number of subjects: 14000

Group type: EXPERIMENTAL
Intervention: Standardized Test Protocols
Number of subjects: 14000

Group type: EXPERIMENTAL
Intervention: Technician Training and Certification Procedures
Number of subjects: 14000

Group type: EXPERIMENTAL
Intervention: Quality Control Assessment Techniques
Number of subjects: 14000
Study: 3440104

Group type: EXPERIMENTAL
Intervention: Activated charcoal 5 g orally at hourly intervals for 7 h
Number of subjects: 8

Group type: COMPARATOR
Intervention: Equal volume of water
Number of subjects: 8
Study: 31524008

Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd:YAG laser (1,064 nm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Topical placebo
Number of subjects: 22
Study: 29301544

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 120
Study: 27502225

Group type: EXPERIMENTAL
Intervention: Bag immersion method using 60mL of 2% chlorhexidine with 70% alcohol
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard gauze painting using 2% chlorhexidine with 70% alcohol
Number of subjects: 51
Study: 25605828

Group type: EXPERIMENTAL
Intervention: Electronic drainage system
Number of subjects: 105

Group type: COMPARATOR
Intervention: Traditional water seal drainage
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Presence of pleural adhesions or incomplete fissure
Number of subjects: 105